- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Diasonics develops new Gateway beamformer
Diasonics will use the RSNA meeting to introduce the latest memberof its Gateway scanner family, Gateway fx. The system makes useof a new expanded-aperture beamformer that combines the best ofanalog and digital beamformers, according to Ken Marich,
Diasonics will use the RSNA meeting to introduce the latest memberof its Gateway scanner family, Gateway fx. The system makes useof a new expanded-aperture beamformer that combines the best ofanalog and digital beamformers, according to Ken Marich, directorof marketing communications for the Santa Clara, CA, vendor.
The new beamformer produces very high dynamic range, betterimage quality, and increased Doppler sensitivity, Marich said.The new beamformer also enables the scanner to extend the focusof Diasonics' 2-D transducers into the deep abdomen. In addition,Gateway fx features a larger 12-inch dual monitor.
Gateway fx has 510(k) clearance, and Diasonics plans to beginshipments shortly after the RSNA show, with the scanner sellingfor $150,000 to $200,000.
Other new features to be shown in the Diasonics exhibit includeOB Advisory, an ob package that enhances the ability to determinethe gestational age of a fetus; SmartCaliper for the automatedplacement of measurement calipers; and OB Trend Analysis, whichenables clinicians to track six key fetal growth factors.
In the networking arena, Diasonics has expanded its supportfor the DICOM 3.0 print and storage classes to enable its scannersto make direct connections to DICOM-compatible workstations.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
